Apheresis devices market to grow by USD 1.59B from 2024-28

The global apheresis devices market size is estimated to grow by USD 1.59 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 8.45% during the forecast period. Apheresis devices are utilized for separating components from whole blood, including plasma, platelets, white blood cells, and immunoglobulins. These devices find applications in treating various conditions such as bone marrow disorders, kidney diseases, neurological disorders, blood cancer, and autoimmune diseases. Key components include apheresis equipment, membrane filtration systems, centrifugation equipment, and membrane separation equipment. Apheresis procedures are essential for trauma cases, chronic diseases, and blood transfusions. Devices include portable apheresis devices and automated apheresis machines. Blood donation centers provide essential resources for apheresis procedures.

Segment overview
This apheresis devices market report extensively covers market segmentation by Product (Systems, Consumables) Application (Neurological disorders, Haematological disorders, Renal disorders, Autoimmune disorders) Geography (North America, Europe, Asia, Rest of World (ROW))

Market segmentation by product
The apheresis devices market encompasses innovative equipment and machines used for selective blood component separation, primarily for therapeutic purposes in various disorders. These include kidney diseases, metabolic disorders, neurological conditions, and blood cancers such as leukemia, lymphoma, and myeloma. Apheresis is instrumental in removing harmful substances like toxins, immune complexes, and excess proteins from the blood for therapeutic purposes. Notable applications include bone marrow, lymph nodes, and spleen processing for transplants, CDC-recommended apheresis procedures for blood donation centers, and trauma cases requiring platelet and white blood cell separation. Apheresis equipment includes centrifugation and membrane separation systems, with membrane filtration being a crucial technology. Additionally, automated devices are gaining popularity for their efficiency and ease of use. Apheresis treatments also extend to blood-related disorders like GVHD and photopheresis, as well as gene therapies and blood transfusions. Portable apheresis devices offer increased accessibility for patients with chronic diseases.

Geography overview
The apheresis devices market in North America is experiencing significant growth due to the increasing prevalence of blood-related disorders such as Cardiovascular Diseases (CVDs) and neurological disorders, a rising number of surgical procedures, and increasing awareness of apheresis procedures among healthcare professionals. Technologically advanced medical devices, including portable apheresis devices, are driving market expansion. Apheresis is used for various therapeutic purposes, including the treatment of leukemia, lymphoma, myeloma, autoimmune diseases, and cancer. It is also utilized in blood transfusions, gene therapies, and photopheresis treatments for conditions like Graft-Versus-Host Disease (GVHD). Apheresis equipment is used for membrane filtration, plasma therapy, and clinical apheresis, which involves the separation of components such as platelets, white blood cells, and red blood cells (RBC units) from whole blood. Apheresis is essential in the production of platelets for transfusions and in the treatment of SARS CoV2 infection through convalescent plasma therapy. Additionally, apheresis is used in the treatment of hematological disorders, including sickle cell disease, and in the processing of drugs and vaccines. The market is further driven by the increasing presence of vendors manufacturing apheresis devices and the growing technological advances in apheresis procedures. However, concerns regarding blood contamination and the need for disposable apheresis kits remain challenges for the market. The CDC also emphasizes the importance of apheresis in the treatment of kidney diseases, metabolic diseases, and neurological disorders.

Research analysis
The apheresis devices market encompasses advanced technologies used for therapeutic blood processing, including portable apheresis devices and clinical apheresis equipment. These devices play a crucial role in managing various blood-related disorders, such as leukemia, lymphoma, myeloma, and autoimmune diseases. Apheresis is employed for therapeutic purposes, including blood transfusions, plasma therapy, and convalescent plasma therapy during SARS CoV2 infection. Apheresis machines utilize membrane filtration, centrifugation equipment, and membrane separation equipment for RBC units, platelets, and white blood cells collection. Apheresis kits and disposable apheresis kits are essential components of these systems, ensuring efficient and safe blood donor experiences. The market for apheresis devices continues to grow, driven by the increasing demand for effective treatments for cancer and other blood disorders. Technavio